ACE2 and infection: Analysis of ACE2 expression behavior among symptomatic patients (Figure 1) revealed low expression levels of before infection, which increased significantly during SARS-CoV-2 infection (p < 0.01) and decreased significantly after the infection (p < 0.001), returning to approximately the levels observed before the infection.